Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNK2 | Q07912 | 2/20 | 0.31 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.30 |
| ▸ | POLRMT | O00411 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23425920 | 0.86 | TNK2 (0.30) | TNK2 | |
| SCHEMBL24866019 | 0.86 | TNK2 (0.30) | TNK2 | |
| SCHEMBL18666902 | 0.81 | POLRMT (0.33) | TNK2RIPK1POLRMT | |
| SCHEMBL20144199 | 0.81 | POLRMT (0.33) | TNK2RIPK1POLRMT | |
| SCHEMBL25608469 | 0.79 | MGLL (0.39) | TNK2RIPK1 | |
| SCHEMBL22355511 | 0.78 | POLRMT (0.31) | POLRMT | |
| SCHEMBL24789459 | 0.78 | RIPK1 (0.33) | RIPK1POLRMT | |
| SCHEMBL807536 | 0.77 | ACVRL1 (0.32) | TNK2RIPK1POLRMT | |
| SCHEMBL23047661 | 0.77 | ACVRL1 (0.32) | TNK2RIPK1POLRMT | |
| SCHEMBL20144205 | 0.77 | DOT1L (0.35) | TNK2POLRMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210228605-A1 | ISOMORPHS OF REMDESIVIR AND METHODS FOR SYNTHESIS OF SAME | Anzalp Pharmasolutions Pvt. Ltd. (IN) | 2021-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210228605-A1 | ISOMORPHS OF REMDESIVIR AND METHODS FOR SYNTHESIS OF SAME | MTAP, SARS1, PNP | TNK2 3935/4885RIPK1 2138/4885POLRMT 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.